Paloma Partners’s Ironwood Pharmaceuticals IRWD Stock Holding History

Paloma Partners’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-22,676	Closed	-$204K	–	1927
2020 Q3	$204K	Buy	+22,676	New	+$225K	0.01%	1744
2019 Q4	–	Sell	-10,056	Closed	-$86K	–	2327
2019 Q3	$86K	Buy	+10,056	New	+$97.7K	﹤0.01%	1848
2019 Q2	–	Sell	-76,219	Closed	-$864K	–	1963
2019 Q1	$864K	Buy	+76,219	New	+$851K	0.02%	801
2018 Q2	–	Sell	-73,804	Closed	-$954K	–	1913
2018 Q1	$954K	Sell	73,804 -14,538	-16%	-$181K	0.02%	1011
2017 Q4	$1.11M	Sell	88,342 -39,854	-31%	-$521K	0.01%	988
2017 Q3	$1.69M	Buy	128,196 +65,740	+105%	+$905K	0.02%	851
2017 Q2	$988K	Sell	62,456 -12,327	-16%	-$179K	0.01%	1204
2017 Q1	$1.07M	Sell	74,783 -30,277	-29%	-$414K	0.01%	1200
2016 Q4	$1.34M	Buy	105,060 +24,153	+30%	+$305K	0.01%	978
2016 Q3	$1.08M	Buy	+80,907	New	+$946K	0.01%	967
2016 Q2	–	Sell	-22,083	Closed	-$202K	–	2230
2016 Q1	$202K	Buy	+22,083	New	+$182K	﹤0.01%	1692

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Paloma Partners's IRWD Position: Q4 2020 in Review

Paloma Partners sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2020, closing a stake of 22,676 shares — an estimated $204K sold.

Paloma Partners first reported a position in IRWD in Q1 2016 and held it in 11 quarters. The position peaked at $1.69M in Q3 2017. 199 funds tracked by Wall St. Rank hold IRWD as of Q4 2020.

Paloma Partners reported no remaining Ironwood Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Paloma Partners sold 22,676 Ironwood Pharmaceuticals shares in Q4 2020, an estimated $204K.
Paloma Partners first reported a position in Ironwood Pharmaceuticals in Q1 2016 and held it in 11 quarters.
Paloma Partners's Ironwood Pharmaceuticals position peaked at $1.69M in Q3 2017.
199 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2020.

Based on Paloma Partners's 13F filing for Q4 2020, filed 16 Feb 2021.